← ANALYSTS · TIPRANKS
Srikripa Devarakonda · Truist Financial
Hits
62%
225 of 360 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+26.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
20
Buy / hold / sell: 18 / 2 / 0
Upside of the analyst’s targets
+66.8%
Average over 13 current targets, to the last price
The market’s answer to the ratings
−0.1%
Day-0 move against SPY in the rating’s direction, average over 9 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 14on TipRanks 08:30 | INCYSPYIncyte · $23.0B | Reiterated | Hold | $105 → $115+9.5% | +1.7% | +3.8%next day +1.2% | ↗ |
| Oct 13on TipRanks 07:50 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Buy | $70.00 | +17.2% | −1.6%next day +5.7% | ↗ |
| Oct 13on TipRanks 07:50 | SRRKIWMScholar Rock Holding · $4.9B | Reiterated | Buy | $77.00 | +93.0% | −3.4%next day −1.2% | ↗ |
| Oct 1on TipRanks 11:40 | LLYSPYEli Lilly & Co · $1.2T | Reiterated | Buy | — | — | −0.8%next day −1.3% · 5 days +0.4% | ↗ |
| Sep 29on TipRanks 08:11 | IVAInventiva · $877M | Reiterated | Buy | — | — | −6.6%next day +12.4% · 5 days +3.2% | ↗ |
| Sep 24on TipRanks 07:15 | SRRKIWMScholar Rock Holding · $4.9B | Reiterated | Buy | $76.00 → $77.00+1.3% | +93.0% | −2.4%next day −0.5% · 5 days −4.6% | ↗ |
| Sep 23on TipRanks 07:55 | AXSMAxsome Therapeutics · $8.2B | Initiated | Buy | $200 → $285+42.5% | +81.4% | −4.0%next day +1.4% · 5 days −4.0% | ↗ |
| Sep 23on TipRanks 07:55 | EWTXIWMEdgewise Therapeutics · $4.1B | Reiterated | Buy | — | — | −7.1%next day +0.4% · 5 days −0.4% | ↗ |
| Sep 22on TipRanks 08:10 | NAMSNewAmsterdam Pharma Company · $2.4B | Reiterated | Buy | $57.00 | +187.4% | +3.3%next day −2.0% · 5 days +3.3% | ↗ |
| Sep 1on TipRanks 08:05 | PTGXIWMProtagonist Therapeutics · $8.8B | Reiterated | Buy | — | — | −0.2%next day −0.7% · 5 days −1.0% | ↗ |
| Sep 1on TipRanks 07:30 | CYTKIWMCytokinetics · $8.9B | Reiterated | Buy | $112 | +80.8% | +1.4%next day +0.3% · 5 days +3.7% | ↗ |
| Aug 18on TipRanks 08:25 | OABIIWMOmniAb · $688M | Reiterated | Buy | — | — | +3.3%next day +6.7% · 5 days +19.1% | ↗ |
| Aug 18on TipRanks 07:25 | CORTCorcept Therapeutics · $12.9B | Initiated | Buy | $50.00 → $164+228.0% | +48.9% | +1.5%next day +0.6% · 5 days +4.8% | ↗ |
| Aug 13on TipRanks 22:25 | SEPNIWMSepterna, Inc. · $1.7B | Reiterated | Buy | $43.00 → $59.00+37.2% | +62.3% | −1.2%next day −0.2% · 5 days −8.7% | ↗ |
| Aug 11on TipRanks Aug 12 22:25 | LLYSPYEli Lilly & Co · $1.2T | Reiterated | Buy | $1,376 | +9.5% | −1.1%next day +0.2% · 5 days +1.4% | ↗ |
| Aug 10on TipRanks 10:21 | MBXIWMMBX Biosciences, Inc. · $2.4B | Reiterated | Buy | $70.00 → $88.00+25.7% | +77.4% | −2.4%next day +0.1% · 5 days +3.2% | ↗ |
| Aug 10on TipRanks 08:07 | ARVNIWMArvinas Holding Company · $468M | Assigned | Hold | $8.68 | +24.5% | +2.8%next day +0.3% · 5 days +2.4% | ↗ |
| Jul 31on TipRanks 07:40 | MDGLMadrigal Pharmaceuticals · $10.4B | Reiterated | Buy | $709 | +57.6% | −6.0%next day +1.7% · 5 days +5.6% | ↗ |
| Jul 31on TipRanks 07:36 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Buy | $65.00 → $70.00+7.7% | +17.2% | 0.0%next day −1.2% · 5 days −4.4% | ↗ |
| Jul 29on TipRanks 10:39 | ALTIWMAltimmune · $459M | Reiterated | Buy | — | — | −0.8%next day +0.4% · 5 days −1.8% | ↗ |
| Jul 29on TipRanks 09:09 | INCYSPYIncyte · $23.0B | Reiterated | Hold | — | — | −0.6%next day −4.9% · 5 days −11.3% | ↗ |
| Jul 2on TipRanks 07:43 | ABSIIWMAbSci · $1.5B | Reiterated | Buy | $11.00 → $17.00+54.5% | +106.1% | +4.7%next day −1.6% · 5 days −10.1% | ↗ |
| Jun 29on TipRanks 07:44 | KYMRIWMKymera Therapeutics · $9.0B | Assigned | Buy | $116 → $136+17.2% | +29.8% | −0.5%next day +4.1% · 5 days +8.2% | ↗ |
| May 15on TipRanks 08:25 | KROSIWMKeros Therapeutics · $219M | Reiterated | Buy | — | — | −3.3%next day −3.2% · 5 days +5.7% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗